BeyondSpring Inc. - 8-K Filing

BeyondSpring reports Q3 2026 net loss of $2.1 million and announces FDA Fast Track designation for Plinabulin plus docetaxel. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)

SEC EDGAR · November 13, 2026, 22:27 UTC

Tickers: $BYSI

Read the full article at SEC EDGAR

Part of the story NextPlat Corp - 8-K Filing (3 articles)

More Regulatory news

Alset Inc. - 10-Q Filing SEC EDGAR · November 13, 2026, 22:32 UTC
Trump Media & Technology Group Corp. - 4 Filing SEC EDGAR · November 13, 2026, 22:29 UTC
PERPETUA RESOURCES CORP. - 10-Q Filing SEC EDGAR · November 13, 2026, 22:29 UTC
Trump Media & Technology Group Corp. - 4 Filing SEC EDGAR · November 13, 2026, 22:28 UTC
Dragonfly Energy Holdings Corp. - 10-Q Filing SEC EDGAR · November 13, 2026, 22:28 UTC
SYNTEC OPTICS HOLDINGS, INC. - 10-Q Filing SEC EDGAR · November 13, 2026, 22:28 UTC
MACROGENICS INC - 8-K Filing SEC EDGAR · November 13, 2026, 22:28 UTC
Trump Media & Technology Group Corp. - 4 Filing SEC EDGAR · November 13, 2026, 22:28 UTC
Canary XRP ETF - 10-Q Filing SEC EDGAR · November 13, 2026, 22:27 UTC
Eightco Holdings Inc. - 10-Q Filing SEC EDGAR · November 13, 2026, 22:27 UTC